Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Common Stock Issuable [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 11,912 $ 22,738,574 $ 430 $ (28,539,953) $ (5,789,037)
Balance, shares at Dec. 31, 2017 119,118,513        
Common shares issued upon exercise of warrants $ 1,191 20,809 22,000
Common shares issued upon exercise of warrants, shares 11,917,705        
Common shares issued upon exercise of options $ 49 34,084 $ 34,133
Common shares issued upon exercise of options, shares 487,620       487,620
Proceeds from sale of common stock $ 1,746 2,976,754 $ 2,978,500
Proceeds from sale of common stock, shares 17,459,067       1,679,276
Fair Value of warrants issued for debt extension 1,074,602 $ 1,074,602
Fair value of common shares issued for services $ 479 1,547,380 (430) 1,547,429
Fair value of common shares issued for services, shares 4,790,181        
Fair value of common stock issued upon conversion of debt $ 1,865 3,063,972 3,065,837
Fair value of common stock issued upon conversion of debt, shares 18,647,831        
Fair value of common stock issued upon conversion of accrued expenses $ 41 582,292 582,333
Fair value of common stock issued upon conversion of accrued expenses, shares 407,226        
Common shares issued upon exercise of put option $ 305 999,695 1,000,000
Common shares issued upon exercise of put option, shares 3,048,105        
Fair value of vested stock options 1,413,304 1,413,304
Stock repurchase $ (70) (19,930) (20,000)
Stock repurchase, shares (700,000)        
Net loss (8,192,523) (8,192,523)
Balance at Sep. 30, 2018 $ 17,518 $ 34,431,536 $ (36,732,476) $ (2,283,422)
Balance, shares at Sep. 30, 2018 175,176,248